Dash Bio

Dash Bio is a next-generation bioanalysis CRO that provides an automated platform using AI, robotics, and software to accelerate clinical drug development for pharmaceutical and biotech companies. They deliver GLP-compliant assays, such as ELISA, LC-MS, and qPCR, up to 10x faster than traditional CROs. The company earns revenue through bioanalytical services and likely usage-based SaaS for its management software.